Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-13

Clinical Trial Update: Trial to Evaluate the Efficacy of Simvastatin for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating simvastatin for smoking cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED